我公司致力于為客戶提供高純度、低成本的活性重組蛋白，包括重組人VSIG4在內的各類受體、細胞因子、生長因子、轉錄因子、激素、酶、毒性蛋白、病毒抗原等。...

特別提示：包括重組人VSIG4(含V-set和Ig結構域蛋白4)在內，本公司的所有產品僅可用于科研實驗，嚴禁用于臨床醫(yī)療及其他非科研用途！

產品名稱：重組人VSIG4(含V-set和Ig結構域蛋白4)
英文名稱：Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4
產品貨號：JN0620
產品規(guī)格：10μg|50μg|500μg|1mg

本品由我們的哺乳動物細胞表達系統(tǒng)制備而成，目的基因編碼的Arg20-Pro283在C端含有His標簽。

VSIG4質量控制：＞95%(還原性SDS-PAGE)

VSIG4制劑：凍干品

VSIG4保存：
凍干蛋白置于-20℃以下可長期保存，室溫條件下可穩(wěn)定保存3周。
復溶蛋白溶液可在4～7℃保存2～7天，可分裝后置于-20℃保存三個月。

VSIG4復溶：
打開試劑管前請先離心。
復溶濃度推薦大于100 μg/ml。
凍干蛋白請溶于ddH2O。
復溶后，請根據用量分裝凍存，避免反復凍融。

關于VSIG4：
V-Set and Immunoglobulin Domain-Containing Protein 4 (VSIG4) is a 45-50 kDa macrophage-specific transmembrane glycoprotein that belongs to the B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type Ig domain and a truncated C-type Ig domain. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. It is also expressed in resting macrophages. No VSIG4 expression appears to be present in T and B cells. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. It is a potent inhibitor of the alternative complement pathway convertases. Human VSIG4 is 399 amino acids (aa) in length. It is a type I transmembrane (TM) glycoprotein that contains a 264 aa extracellular domain (ECD) (aa 20 - 283) and a 95 aa cytoplasmic region.

根據您的關注的重組人VSIG4(含V-set和Ig結構域蛋白4)，重組VSIG4，rVSIG4，重組人含V-set和Ig結構域蛋白4，rhVSIG4，重組人VSIG4(含V-set和Ig結構域蛋白4)，重組人V-Set and Immunoglobulin Domain-Containing Protein 4，含V-set和Ig結構域蛋白4，重組含V-set和Ig結構域蛋白4，重組人VSIG4，重組V-Set and Immunoglobulin Domain-Containing Protein 4，Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4，JN0620，百奧萊博，，，您可能還對以下產品有需求：



名稱：重組長尾獼猴成纖維生長因子21
貨號：JN0285
規(guī)格：10μg|50μg|500μg|1mg
本品由我們的哺乳動物表達系統(tǒng)制備，目的基因編碼的His29-Ser209在C端含有His標簽。

FGF-21質量控制：＞95%(還原性SDS-PAGE)。

FGF-21制劑：凍干品

FGF-21保存：
凍干蛋白可在-20℃長期保存，室溫也可穩(wěn)定保存3周。
復溶蛋白溶液可在4～7℃保存2～7天。
復溶后建議分裝凍存在-20℃，可保存3個月，應避免反復凍融。

FGF-21復溶：
1、試劑開蓋前請先離心。
2、復溶濃度應大于100 μg/ml.
3、凍干蛋白溶于ddH2O中
4、復溶后根據使用量分裝保存，避免反復凍融。

關于FGF-21：
Fibroblast Growth Factor 21 (FGF21) is a growth factor that belongs to the FGF family. FGF family proteins play a central role during prenatal development and postnatal growth and regeneration of mamy tissues, by promoting cellular proliferation and differentiation. FGF21 is a potent activator of glucose uptake on adipocytes, protects animal from diet-induced obesity when overexpression in transgenic mice, and lower blood glucose and triglyceride levels when therapeutically adiministered to diabetic redents. FGF21 is produced by hepatocytes in reponse to free fatty acid stimulation of a PPARa/RXR dimeric complex. This situation occurs clinically during starvation, or following the ingestionof a highly-fat/low-carbohydrate diet. Upon FGF21 secretion, white adipose tissue is induced to release free fatty acids from triglyceride stores. once free fatty acid reach hepatocytes, they are oxidized and reduced to acetyl-CoA. The acetyl-CoA is recombined into 4-carbon ketone bodies, release, and transported to peripheral tissue for TCA processing and energy generation.

關注重組人VSIG4(含V-set和Ig結構域蛋白4)，重組VSIG4，rVSIG4，重組人含V-set和Ig結構域蛋白4，rhVSIG4，重組人VSIG4(含V-set和Ig結構域蛋白4)，重組人V-Set and Immunoglobulin Domain-Containing Protein 4，含V-set和Ig結構域蛋白4，重組含V-set和Ig結構域蛋白4，重組人VSIG4，重組V-Set and Immunoglobulin Domain-Containing Protein 4，Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4，JN0620，百奧萊博，，的同時，為您推薦更多您可能感興趣的產品：


JN0427 重組人干擾素α1(IFN-α1) 10μg|50μg|500μg|1mg
JN0509 重組小鼠RANK(TNFRSF11A)(CD265) 10μg|50μg|500μg|1mg
JN1992 重組人細胞質動力蛋白輕鏈1(DYNLL1) 10μg|50μg|500μg|1mg
JN1997 重組人生長停滯特異性蛋白7(GAS-7) 10μg|50μg|500μg|1mg
JN2002 重組人LSM4蛋白 10μg|50μg|500μg|1mg
JN0822 重組人胰脂肪酶相關蛋白2(PNLIPRP2) 10μg|50μg|500μg|1mg
JN0839 重組人透明質酸酶1(Hyaluronidase-1) 10μg|50μg|500μg|1mg

如果您覺得“JN0620 重組人VSIG4”描述資料不夠齊全，請聯(lián)系我們獲取詳細資料。(聯(lián)系時請告訴我從給覽網看到的，我們將給您最大優(yōu)惠！)
本頁鏈接：http://www.blueally.cn/com_bjbiolab01/sell/itemid-8517323.html
已經有989位訪客查看了本頁.